ArticleJournal of the American Pharmacists Association : JAPhA
Perceptions of pharmacist-furnished nicotine replacement therapy among participants who smoke in California.
Article in Journal of the American Pharmacists Association : JAPhA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley.Tobacco use insights · 2025Article
- An Exploration of Access to Tobacco Cessation Services Through Pharmacies in a Medically Underserved Area in California: Accuracy of Telephone Information Regarding Pharmacist-Furnished NRT.Journal of primary care & community healthArticle
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND AND
objectiveCalifornia's Central Valley has high rates of tobacco product use and low rates of access to primary care providers. In 2016, California sought to increase access to cessation treatment by allowing pharmacists to prescribe nicotine replacement therapy (NRT). We sought to identify the extent to which this prescribing authority has been integrated into practice.
methodsFrom December 2023 to May 2024, we surveyed adult California participants (n = 271) who smoke about their smoking patterns, perceptions towards NRT, experiences with receiving tobacco cessation resources in pharmacies. Participants were recruited via email and in person. We analyzed participants' smoking and quitting history, perceptions of NRT, and experiences with tobacco cessation, comparing residents of California's Central Valley (n = 52) to other regions of the state (n = 219).
resultsSmoking rates were comparable for respondents in the Central Valley and those residing in other regions of California, although older respondents tended to smoke more heavily. Respondents had few positive perceptions regarding NRT and expressed concerns about perceived side effects and the risk of dependency; past use of NRT was also associated with lower odds of quitting.
conclusionsDespite the low risks and high efficacy of prescription NRT for tobacco cessation, participants in our sample expressed concerns about its perceived side effects, potential for dependency, and a belief that it was not useful. Our findings suggest that additional efforts are needed to improve education about NRT, such as via pharmacist-provided tobacco cessation services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.